全文获取类型
收费全文 | 26195篇 |
免费 | 2737篇 |
国内免费 | 520篇 |
专业分类
耳鼻咽喉 | 138篇 |
儿科学 | 1042篇 |
妇产科学 | 799篇 |
基础医学 | 631篇 |
口腔科学 | 180篇 |
临床医学 | 1903篇 |
内科学 | 2293篇 |
皮肤病学 | 145篇 |
神经病学 | 218篇 |
特种医学 | 515篇 |
外国民族医学 | 68篇 |
外科学 | 2501篇 |
综合类 | 3275篇 |
现状与发展 | 2篇 |
预防医学 | 570篇 |
眼科学 | 104篇 |
药学 | 2178篇 |
17篇 | |
中国医学 | 821篇 |
肿瘤学 | 12052篇 |
出版年
2024年 | 42篇 |
2023年 | 300篇 |
2022年 | 579篇 |
2021年 | 1047篇 |
2020年 | 899篇 |
2019年 | 848篇 |
2018年 | 837篇 |
2017年 | 959篇 |
2016年 | 1206篇 |
2015年 | 1102篇 |
2014年 | 1634篇 |
2013年 | 2158篇 |
2012年 | 1481篇 |
2011年 | 1712篇 |
2010年 | 1293篇 |
2009年 | 1305篇 |
2008年 | 1275篇 |
2007年 | 1427篇 |
2006年 | 1300篇 |
2005年 | 1089篇 |
2004年 | 873篇 |
2003年 | 786篇 |
2002年 | 696篇 |
2001年 | 633篇 |
2000年 | 518篇 |
1999年 | 494篇 |
1998年 | 393篇 |
1997年 | 398篇 |
1996年 | 284篇 |
1995年 | 265篇 |
1994年 | 255篇 |
1993年 | 169篇 |
1992年 | 143篇 |
1991年 | 136篇 |
1990年 | 109篇 |
1989年 | 100篇 |
1988年 | 86篇 |
1987年 | 79篇 |
1986年 | 65篇 |
1985年 | 80篇 |
1984年 | 71篇 |
1983年 | 62篇 |
1982年 | 42篇 |
1981年 | 45篇 |
1980年 | 41篇 |
1979年 | 34篇 |
1978年 | 34篇 |
1977年 | 26篇 |
1976年 | 27篇 |
1975年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
21.
A. GURBUZ A. KARATEKE C. KABACA G. KIR & E. CETINGOZ 《International journal of gynecological cancer》2006,16(S1):307-312
Abstract. Gurbuz A, Karateke A, Kabaca C, Kir G, Cetingoz E. Peritoneal tuberculosis simulating advanced ovarian carcinoma: is clinical impression sufficient to administer neoadjuvant chemotherapy for advanced ovarian cancer? Int J Gynecol Cancer 2006; 16(Suppl. 1): 307–312.
Peritoneal tuberculosis mimics advanced ovarian cancer because of the similarities in clinical signs and symptoms such as ascites, pelvic and abdominal pain and mass, and elevation of serum CA125 level. We have presented four cases of peritoneal tuberculosis that underwent exploratory laparotomy for suspected advanced ovarian cancer during a 3-year period. Definitive diagnosis of tuberculosis was performed at laparotomy in all the cases. The frozen-section analysis seems to be the gold standard in the differential diagnosis. In view of these data, clinical diagnosis of advanced ovarian cancer is not sufficient for administering neoadjuvant chemotherapy. Cytologic or pathologic findings must be consistent with ovarian cancer for candidates who are being considered for neoadjuvant chemotherapy. 相似文献
Peritoneal tuberculosis mimics advanced ovarian cancer because of the similarities in clinical signs and symptoms such as ascites, pelvic and abdominal pain and mass, and elevation of serum CA125 level. We have presented four cases of peritoneal tuberculosis that underwent exploratory laparotomy for suspected advanced ovarian cancer during a 3-year period. Definitive diagnosis of tuberculosis was performed at laparotomy in all the cases. The frozen-section analysis seems to be the gold standard in the differential diagnosis. In view of these data, clinical diagnosis of advanced ovarian cancer is not sufficient for administering neoadjuvant chemotherapy. Cytologic or pathologic findings must be consistent with ovarian cancer for candidates who are being considered for neoadjuvant chemotherapy. 相似文献
22.
J. M. Falletta B. Cushing S. Lauer B. Bell D. H. Mahoney R. Castleberry R. A. Krance 《Investigational new drugs》1990,8(2):167-170
Summary We conducted a phase I clinical study of aziridinylbenzoquinone (Diaziquone, AZQ) given as a 4 hour infusion weekly × 4. Forty-five children with recurrent acute leukemia and 33 children with various advanced solid tumors participated. Severe myelosuppression was the dose limiting toxic effect, occurring in all patients at the upper dose levels. Gastrointestinal and hepatic toxicities were infrequent and not severe. No allergic reactions occurred. Objective tumor regression was noted in 3 of 25 patients with a CNS tumor and in 6 of 45 patients with acute leukemia. For phase II trials the recommended dosage of Diaziquone given by this schedule is 18 mg/M2×4 for patients with a solid tumor, and is 30 mg/M2/week × 4 for children with acute leukemia. 相似文献
23.
本文报道了我院收治的卵巢恶性畸胎瘤31例,随访中2例失访,随访率为93.53%。并讨论了卵巢恶性畸瘤的治疗方式为手术加联合化疗,对年轻的I期患者可行患侧单侧附件切除术,术后化疗极为重要。化疗方法采用VAC或PVB方案联合化疗,本文还 影响预后的重要因素为临床分期期和病理学特点. 相似文献
24.
分析原发性腹膜后恶性肿瘤12例。83%以腹块和腹痛为主要症状,体征中腹块占91.5%,以恶性淋巴瘤居首位占61%。全组完全切除率为58%,行脏器联合切除占25%。完全切除加放疗、化疗3年存活率为28.5%,部分切除及活检未给其它治疗者5例预后差,均1年内死亡,差别显著。 相似文献
25.
Uptake of Adriamycin in tumour and surrounding brain tissue in patients with malignant gliomas 总被引:1,自引:0,他引:1
H. von Holst E. Knochenhauer H. Blomgren V. P. Collins L. Ehn M. Lindquist G. Norén C. Peterson 《Acta neurochirurgica》1990,104(1-2):13-16
Summary Eight patients with malignant gliomas verified on CT scan, received an intravenous injection of 50 mg of Adriamycin R, 24 hours prior to surgical removal of the tumour. Peroperatively, both tumour and surrounding tissue specimens were obtained for determination of the tissue concentrations of Adriamycin and its reduced metabolite Adriamycinol. It was found that Adriamycin could be detected in tumour tissue from all patients. The concentration varied between 0,9 and 4,6 nmol/g tissue. In contrast, Adriamycin could only be detected in surrounding brain tissue from one patient.In anin vitro study a human malignant glioma cell line (U-251 MG) was exposed to various concentrations of Adriamycin for 24 hours. It was found that an intracellular drug concentration above 30 nmol/g cells caused a concentration dependent inhibition of cell growth. Thus, it is likely that the poor effect of Adriamycin on patients with malignant gliomas is due to an ineffective drug accumulation in the tumour tissue. 相似文献
26.
长春瑞滨加异环磷酰胺加顺铂治疗晚期非小细胞肺癌98例临床疗效观察 总被引:2,自引:0,他引:2
吴海默 《中国肿瘤临床与康复》2005,12(4):338-339
目的观察长春瑞滨(NVB)、异环磷酰胺(IFO)、顺铂(PDD)三药联合(NIP)治疗晚期非小细胞肺癌的疗效和毒性.方法共收治ⅢB~Ⅳ期非小细胞肺癌98例,其中鳞癌51例,腺癌42例,大细胞癌5例.ⅢB期59例,Ⅳ期39例.初治71例,复治27例.方案:NVB 25 mg/m2静滴,第1,8天;IFO 1.5 g/m2,静滴,第1~3天;PDD 30 mg/m2,静滴,第1~3天.4周为一周期.结果 CR 1例,PR 44例,NC 45例,PD 8例,总有效率(CR PR)为45.9%.中位缓解期8个月,中位生存期11个月,1年生存率为48.0%.骨髓抑制为剂量限制性毒性,其中Ⅲ~Ⅳ度占40.8%.结论 NIP方案是治疗晚期非小细胞肺癌有效且安全的方案. 相似文献
27.
善存片联合健脾理气中药预防肿瘤患者化疗所致口腔溃疡的临床观察 总被引:1,自引:0,他引:1
目的观察在全身化疗前应用善存片联合健脾理气中药对肿瘤患者口腔溃疡的预防作用。方法将66例肿瘤患者随机分配为治疗组和对照组,每组33例。在全身静脉化疗前3天开始,治疗组每天口服善存片1片及健脾理气中药1剂,对照组服用维生素B:治疗,两组服药化疗后10天为1个疗程。每周期化疗结束后统计口腔溃疡的发生率,共4周期。结果治疗组口腔溃疡的发生率显著降低(P〈0.01)。结论善存片联合健脾理气中药可有效预防及治疗肿瘤患者化疗所致的口腔溃疡。 相似文献
28.
卵巢未成熟畸胎瘤43例综合治疗疗效分析 总被引:3,自引:0,他引:3
为探讨不同手术方式及化疗方法对卵巢未成熟畸胎瘤的疗效及相关影响因素,对43例卵巢未成熟畸胎瘤患者进行回顾性分析。手术方式分为:保守性手术(患侧附件、大网膜切除术+盆、腹腔腹膜结节切除术+盆腔淋巴结清扫术)及根治性手术(全子宫、双附件及大网膜切除术_肿瘤细胞减灭术+盆腔淋巴结清扫术)。术后采用VAC(长春新碱,阿霉素,环磷酰胺)方案、BEP(博莱霉素或平阳霉素,足叶乙叉甙,顺铂或卡铂)方案或VBP(长春新碱,博莱霉素或平阳霉素,顺铂或卡铂)方案进行联合化疗。患者5年生存率根治性手术为44.4%,保守性手术为64.0%,差异无显著性。VAC方案与BEP(或VBP)方案的5年生存率分别为33.3%和77.3%(P<0.01)。疗程数≥4患者的5年生存率为73.9%,明显高于疗程数<4患者的38.9%(P<0.05)。认为对于有生育要求的卵巢未成熟畸胎瘤患者,可仅行保守性手术,术后辅以联合化疗。BEP(或VBP)方案对患者长期生存率的改善明显优于VAC方案。术后化疗的疗程数与疗效有关,对长期生存率的影响较明显。 相似文献
29.
目的观察以表阿霉素为主的不同化疗方案对常见恶性肿瘤的疗效及其毒副作用。方法以表阿霉素为主的CEP、CEOP、TE、IEO方案治疗肺癌、非霍奇金淋巴瘤、晚期乳腺癌和横纹肌肉瘤,其中表阿霉素60mg/m^2分2天静脉注射,其他药物都为常规剂量。21~28天为1个治疗周期,治疗2~3个周期后评价疗效。结果全组29例中CR7例,PR13例,SD5例,PD4例,总有效率68.97%。主要不良反应为骨髓抑制,其次是脱发和消化道反应。对肝肾功能和心脏影响轻微。结论以表阿霉素为主的联合化疗方案对常见恶性肿瘤疗效佳,安全性好,患者能较好地耐受。 相似文献
30.
C. R. Gálvez V. C. Fernández J. M. R. De Los Reyes M. M. M. Jaén & R. G. Teruel 《International journal of gynecological cancer》2004,14(5):1040-1044
Choriocarcinoma is one of the most serious forms of gestational trophoblastic tumor. It is a malignant tumor from the epithelium of the chorionic villi. The most frequent location site is the uterus. Associated with ectopic pregnancy, it is extremely rare and in general, very aggressive. In 75% of the cases, it items from distant metastasis; therefore, a histological examination of the tubes must be performed in all ectopic pregnancies. Our patient was a 33-year-old woman who was admitted to emergency room (ER) with an intense pain in the right, iliac cavity, and limited genital bleeding. During the exploration, there was abdominal pain, with doubtful signs of peritoneal irritation. The vaginal ultrasound offered an image that was compatible with an extra uterine pregnancy in the left appendages. At emergency, right salpingectomy was performed via laparotomy. The patient was treated with polychemotherapy and contraceptives for a year, with no recurrence of the disease. Control follow-up was performed using beta-human chorionic gonadotropin (HCG) testing on a weekly basis during the first month and then bi-monthly during the first year of follow-up. 相似文献